You, S

A genital tract peptide epitope vaccine targeting TLR-2 efficiently induces local and systemic CD8+ T cells and protects against herpes simplex virus type 2 challenge

Zhang, X., Chentoufi, A. A., Dasgupta, G., Nesburn, A. B., Wu, M., Zhu, X., Carpenter, D., Wechsler, S. L., You, S., & BenMohamed, L. (2009) · Mucosal Immunology

Herpesvirus Infections and TreatmentsImmunotherapy and Immune Responses

Cited by 110